Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS
admin 10th November 2017 Uncategorised 0Cost watchdogs in England and pharma don’t always see eye to eye, but the sides are celebrating two new deals on Merck KGaA’s Mavenclad and Roche’s Perjeta.
More: Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS
Source: fierce